Search
Results: 9
Spatial Lifecourse Epidemiology Reporting Standards (ISLE-ReSt) statement.
Peng Jia, Chao Yu, Justin V Remais, Alfred Stein, Yu Liu, Ross C Brownson, Jeroen Lakerveld, Tong Wu, Lijian Yang, Melody Smith, Sherif Amer, Jamie Pearce, Yan Kestens, Mei-Po Kwan, Shengjie Lai, Fei Xu, Xi Chen, Andrew Rundle, Qian Xiao, Hong Xue, Miyang Luo, Li Zhao, Guo Cheng, Shujuan Yang, Xiaolu Zhou, Yan Li, Jenna Panter, Simon Kingham, Andy Jones, Blair T Johnson, Xun Shi, Lin Zhang, Limin Wang, Jianguo Wu, Suzanne Mavoa, Tuuli Toivonen, Kevin M Mwenda, Youfa Wang, WM Monique Verschuren, Roel Vermeulen, Peter James
Nov 21, 2019
Spatial lifecourse epidemiology is an interdisciplinary field that utilizes advanced spatial, location-based, and artificial intelligence technologies to investigate the long-term effects of environmental, behavioural...
Artificial Intelligence big data Exposome Exposomics ISLE Lifecourse epidemiology Location-based Reporting guideline Reporting standard Spatial epidemiology Spatial lifecourse epidemiology Advisory Committees Artificial Intelligence Checklist Cohort Studies Epidemiologic Studies health status Humans Internationality Public Health Research Design Spatial Analysis
Transparency in practice
Piotr Ozierański, Olga Löblová, Natalia Nicholls, Marcell Csanádi, Zoltán Kaló, Martin McKee, Lawrence King
Feb 13, 2018
Transparency is recognised to be a key underpinning of the work of health technology assessment (HTA) agencies, yet it has only recently become a subject of systematic inquiry. We contribute to this research field by considering...
Recommendations for the management of secondary hypogammaglobulinaemia due to B cell targeted therapies in autoimmune rheumatic diseases.
Sonali Wijetilleka, David R Jayne, Chetan Mukhtyar, Aftab Ala, Philip D Bright, Hector Chinoy, Lorraine Harper, Majid A Kazmi, Sorena Kiani-Alikhan, Charles K Li, Siraj A Misbah, Louise Oni, Fiona E Price-Kuehne, Alan D Salama, Sarita Workman, David Wrench, Mohammed Yousuf Karim
Nov 27, 2019
OBJECTIVES: The association of B cell targeted therapies with development of hypogammaglobulinaemia and infection is increasingly recognized. Our aim was to develop consensus recommendations for immunoglobulin replacement...
The need for a rationalist turn in evidence-based medicine.
Michael P Kelly
Oct 10, 2018
Biological markers for anxiety disorders, OCD and PTSD: A consensus statement. Part II
Borwin Bandelow, David Baldwin, Marianna Abelli, Blanca Bolea-Alamanac, Michel Bourin, Samuel R Chamberlain, Eduardo Cinosi, Simon Davies, Katharina Domschke, Naomi Fineberg, Edna Grünblatt, Marek Jarema, Yong-Ku Kim, Eduard Maron, Vasileios Masdrakis, Olya Mikova, David Nutt, Stefano Pallanti, Stefano Pini, Andreas Ströhle, Florence Thibaut, Matilde M Vaghi, Eunsoo Won, Dirk Wedekind, Adam Wichniak, Jade Woolley, Peter Zwanzger, Peter Riederer
Aug 15, 2016
When and how to update systematic reviews
Paul Garner, Sally Hopewell, Jackie Chandler, Harriet MacLehose, Holger J Schünemann, Elie A Akl, Joseph Beyene, Stephanie Chang, Rachel Churchill, Karin Dearness, Gordon Guyatt, Carol Lefebvre, Beth Liles, Rachel Marshall, Laura Martínez García, Chris Mavergames, Mona Nasser, Amir Qaseem, Margaret Sampson, Karla Soares-Weiser, Yemisi Takwoingi, Lehana Thabane, Marialena Trivella, Peter Tugwell, Emma Welsh, Ed C Wilson, Holger J Schünemann, Panel for updating guidance for systematic reviews (PUGs)
Aug 16, 2016
The process of developing evidence-based guidance in medicine and public health
BACKGROUND: There has been significant investment in developing guidelines to improve clinical and public health practice. Though much is known about the processes of evidence synthesis and evidence-based guidelines...
Dangerous diagnostics? Regulatory reform in the genomic era
Molecular diagnostics are expanding rapidly yet many have not been externally evaluated. Kelly Holloway and colleagues identify failings in the regulatory system and report on recent efforts at reform
Etiologic Classification Criteria of ARCO on Femoral Head Osteonecrosis Part 1
Byung-Ho Yoon, Lynne C Jones, Chung-Hwan Chen, Edward Y Cheng, Quanjun Cui, Wolf Drescher, Wakaba Fukushima, Valerie Gangji, Stuart B Goodman, Yong-Chan Ha, Philippe Hernigou, Marc Hungerford, Richard Iorio, Woo-Lam Jo, Vikas Khanduja, Harry Kim, Shin-Yoon Kim, Tae-Young Kim, Hee Young Lee, Mel S Lee, Young-Kyun Lee, Yun Jong Lee, Michael A Mont, Takashi Sakai, Nobuhiko Sugano, Masaki Takao, Takuaki Yamamoto, Kyung-Hoi Koo
May 06, 2019
BACKGROUND: Glucocorticoid usage, a leading cause of osteonecrosis of the femoral head (ONFH), and its prevalence was reported in 25%-50% of non-traumatic ONFH patients. Nevertheless, there have been no unified criteria to...